Cellular Phenotypic Transformation in Heart Failure Caused by Coronary Heart Disease and Dilated Cardiomyopathy:

Luojiang Zhu1, Wen Wang2, Changzhen Ren2

  • 1Neurovascular Center, Changhai Hospital, Naval Medical University (Second Military Medical University), Shanghai 200433, China.

Biomedicines
|February 25, 2022
PubMed

Insights

This study reveals how heart cells, including cardiomyocytes, endothelial cells, and fibroblasts, change during heart failure (HF). Understanding these cellular transformations offers new targets for HF treatments.

Area of Science:

  • Cardiovascular Biology
  • Cellular and Molecular Medicine
  • Genomics and Transcriptomics

Background:

  • Heart failure (HF) represents the advanced stage of cardiovascular diseases.
  • While cardiac cellular heterogeneity is known, the specific phenotypic changes in cardiac cells during HF progression are not fully understood.

Purpose of the Study:

  • To investigate the phenotypic transformation of cardiac cells in heart failure using human single-cell RNA transcriptome profiles.
  • To identify specific cellular changes in cardiomyocytes, endothelial cells, and fibroblasts during HF.

Main Methods:

  • Analysis of human single-cell RNA transcriptome data.
  • In vivo validation through animal experiments.
  • Identification of molecular markers associated with cellular phenotypes.

Main Results:

  • Cardiomyocytes (CMs) showed altered myosin subunit expression (decreased MYH6, MYL7; increased MYH7).
  • Endothelial cells (ECs) exhibited two disease phenotypes: inflammatory and muscularized ECs.
  • An increase in myofibroblasts, linked to abnormal extracellular matrix, was observed in HF.

Conclusions:

  • An integrated map of cardiac cellular phenotypic transformation in HF was proposed.
  • Intercellular communication pathways in HF were highlighted.
  • Detailed cellular transformation data can guide the development of cell-based therapeutic targets for HF.